{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:43:19Z","timestamp":1790649799673,"version":"4.1.0"},"reference-count":78,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sanofi-Genzyme"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Rep"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.14814\/phy2.12846","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T01:04:00Z","timestamp":1467248640000},"page":"e12846","source":"Crossref","is-referenced-by-count":22,"title":["Differences in the timing and magnitude of<i>Pkd1<\/i>gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD"],"prefix":"10.14814","volume":"4","author":[{"given":"Kelly A.","family":"Rogers","sequence":"first","affiliation":[{"name":"Department of Rare Renal Disease Research; Sanofi-Genzyme R&D Center; Framingham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Moreno","sequence":"additional","affiliation":[{"name":"Department of Rare Renal Disease Research; Sanofi-Genzyme R&D Center; Framingham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Rare Renal Disease Research; Sanofi-Genzyme R&D Center; Framingham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Husson","sequence":"additional","affiliation":[{"name":"Department of Rare Renal Disease Research; Sanofi-Genzyme R&D Center; Framingham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay O.","family":"Bukanov","sequence":"additional","affiliation":[{"name":"Department of Rare Renal Disease Research; Sanofi-Genzyme R&D Center; Framingham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Ledbetter","sequence":"additional","affiliation":[{"name":"Department of Rare Renal Disease Research; Sanofi-Genzyme R&D Center; Framingham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeva","family":"Budman","sequence":"additional","affiliation":[{"name":"Department of Analytical Research and Development; Sanofi Corporation; Waltham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Programming; Sanofi-Genzyme R&D Center; Framingham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Analytical Research and Development; Sanofi Corporation; Waltham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Ibraghimov-Beskrovnaya","sequence":"additional","affiliation":[{"name":"Department of Rare Renal Disease Research; Sanofi-Genzyme R&D Center; Framingham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Natoli","sequence":"additional","affiliation":[{"name":"Department of Rare Renal Disease Research; Sanofi-Genzyme R&D Center; Framingham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"key":"10.14814\/phy2.12846-BIB0001|phy212846-cit-0001","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-015-3452-x","article-title":"Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients","volume":"152","author":"Binkhorst","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.14814\/phy2.12846-BIB0002|phy212846-cit-0002","doi-asserted-by":"crossref","first-page":"12174","DOI":"10.1073\/pnas.211191098","article-title":"Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene","volume":"98","author":"Boulter","year":"2001","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"10.14814\/phy2.12846-BIB0003|phy212846-cit-0003","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature05348","article-title":"Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine","volume":"444","author":"Bukanov","year":"2006","journal-title":"Nature"},{"key":"10.14814\/phy2.12846-BIB0004|phy212846-cit-0004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00041552-199405000-00017","article-title":"Injury and development in polycystic kidney disease","volume":"3","author":"Calvet","year":"1994","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.14814\/phy2.12846-BIB0005|phy212846-cit-0005","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0022-2275(20)39163-X","article-title":"Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease","volume":"37","author":"Chatterjee","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.14814\/phy2.12846-BIB0006|phy212846-cit-0006","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-8674(95)90339-9","article-title":"Polycystic kidney disease: the complete structure of the PKD1 gene and its protein","volume":"81","author":"Consortium","year":"1995","journal-title":"Cell"},{"key":"10.14814\/phy2.12846-BIB0007|phy212846-cit-0007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1681\/ASN.2011010046","article-title":"Antifibrotic effect of tamoxifen in a model of progressive renal disease","volume":"23","author":"Delle","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0008|phy212846-cit-0008","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0022-2275(20)41159-9","article-title":"Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk\/cpk) mouse","volume":"35","author":"Deshmukh","year":"1994","journal-title":"J. Lipid Res."},{"key":"10.14814\/phy2.12846-BIB0009|phy212846-cit-0009","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1681\/ASN.2006050503","article-title":"Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action","volume":"17","author":"Eddy","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0010|phy212846-cit-0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ki.2009.147","article-title":"Late progression of renal pathology and cyst enlargement is reduced by rapamycin in a mouse model of nephronophthisis","volume":"76","author":"Gattone","year":"2009","journal-title":"Kidney Int."},{"key":"10.14814\/phy2.12846-BIB0011|phy212846-cit-0011","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.1987.121","article-title":"Cyst formation and growth in autosomal dominant polycystic kidney disease","volume":"31","author":"Grantham","year":"1987","journal-title":"Kidney Int."},{"key":"10.14814\/phy2.12846-BIB0012|phy212846-cit-0012","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.00550110","article-title":"Evidence of extraordinary growth in the progressive enlargement of renal cysts","volume":"5","author":"Grantham","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0013|phy212846-cit-0013","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0014|phy212846-cit-0014","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2011.11.001","article-title":"Chain length-specific properties of ceramides","volume":"51","author":"Grosch","year":"2012","journal-title":"Prog. Lipid Res."},{"key":"10.14814\/phy2.12846-BIB0015|phy212846-cit-0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ackd.2009.12.004","article-title":"Determinants of renal disease variability in ADPKD","volume":"17","author":"Harris","year":"2010","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.14814\/phy2.12846-BIB0016|phy212846-cit-0016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu. Rev. Med."},{"issue":"Suppl. 2","key":"10.14814\/phy2.12846-BIB0017|phy212846-cit-0017","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1464-410X.1998.0810s2033.x","article-title":"Development of glomerular filtration and tubular sodium reabsorption in the human fetus and newborn","volume":"81","author":"Haycock","year":"1998","journal-title":"Br. J. Urol."},{"key":"10.14814\/phy2.12846-BIB0018|phy212846-cit-0018","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal. Chem."},{"key":"10.14814\/phy2.12846-BIB0019|phy212846-cit-0019","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng0695-151","article-title":"The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains","volume":"10","author":"Hughes","year":"1995","journal-title":"Nat. Genet."},{"key":"10.14814\/phy2.12846-BIB0020|phy212846-cit-0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.molmed.2011.06.003","article-title":"mTOR signaling in polycystic kidney disease","volume":"17","author":"Ibraghimov-Beskrovnaya","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.14814\/phy2.12846-BIB0021|phy212846-cit-0021","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1100\/tsw.2007.274","article-title":"Increased apoptosis and proliferative capacity are early events in cyst formation in autosomal-dominant, polycystic kidney disease","volume":"7","author":"Ibrahim","year":"2007","journal-title":"ScientificWorldJournal"},{"key":"10.14814\/phy2.12846-BIB0022|phy212846-cit-0022","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.febslet.2009.10.043","article-title":"Significance of glycosphingolipid fatty acid chain length on membrane microdomain-mediated signal transduction","volume":"584","author":"Iwabuchi","year":"2010","journal-title":"FEBS Lett."},{"key":"10.14814\/phy2.12846-BIB0023|phy212846-cit-0023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2353\/ajpath.2006.050342","article-title":"Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1","volume":"168","author":"Jiang","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.14814\/phy2.12846-BIB0024|phy212846-cit-0024","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1681\/ASN.2009030271","article-title":"Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin","volume":"20","author":"Kim","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0025|phy212846-cit-0025","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1093\/nar\/19.15.4293","article-title":"Simplified mammalian DNA isolation procedure","volume":"19","author":"Laird","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.14814\/phy2.12846-BIB0026|phy212846-cit-0026","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1093\/hmg\/ddm299","article-title":"Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice","volume":"16","author":"Lantinga-van Leeuwen","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.14814\/phy2.12846-BIB0027|phy212846-cit-0027","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1681\/ASN.2013080864","article-title":"Scattered deletion of PKD1 in kidneys causes a cystic snowball effect and recapitulates polycystic kidney disease","volume":"26","author":"Leonhard","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0028|phy212846-cit-0028","first-page":"1438","article-title":"Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus","volume":"57","author":"Li","year":"1997","journal-title":"Cancer Res."},{"key":"10.14814\/phy2.12846-BIB0029|phy212846-cit-0029","doi-asserted-by":"crossref","first-page":"a008300","DOI":"10.1101\/cshperspect.a008300","article-title":"Mammalian kidney development: principles, progress, and projections","volume":"4","author":"Little","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.14814\/phy2.12846-BIB0030|phy212846-cit-0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2369-13-109","article-title":"Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease","volume":"13","author":"Liu","year":"2012","journal-title":"BMC Nephrol."},{"key":"10.14814\/phy2.12846-BIB0031|phy212846-cit-0031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng1097-179","article-title":"Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation","volume":"17","author":"Lu","year":"1997","journal-title":"Nat. Genet."},{"key":"10.14814\/phy2.12846-BIB0032|phy212846-cit-0032","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/5944","article-title":"Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes","volume":"21","author":"Lu","year":"1999","journal-title":"Nat. Genet."},{"key":"10.14814\/phy2.12846-BIB0033|phy212846-cit-0033","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1371\/journal.pbio.0040362","article-title":"The liganding of glycolipid transfer protein is controlled by glycolipid acyl structure","volume":"4","author":"Malinina","year":"2006","journal-title":"PLoS Biol."},{"key":"10.14814\/phy2.12846-BIB0034|phy212846-cit-0034","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.ddmec.2013.10.002","article-title":"Murine models of polycystic kidney disease","volume":"10","author":"Menezes","year":"2013","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"10.14814\/phy2.12846-BIB0035|phy212846-cit-0035","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"10.14814\/phy2.12846-BIB0036|phy212846-cit-0036","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1194\/jlr.M009142","article-title":"Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism","volume":"52","author":"Mullen","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.14814\/phy2.12846-BIB0037|phy212846-cit-0037","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.V571462","article-title":"Proliferative activity of cyst epithelium in human renal cystic diseases","volume":"5","author":"Nadasdy","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0038|phy212846-cit-0038","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1523-1755.2003.00755.x","article-title":"Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease","volume":"63","author":"Nagao","year":"2003","journal-title":"Kidney Int."},{"key":"10.14814\/phy2.12846-BIB0039|phy212846-cit-0039","doi-asserted-by":"crossref","first-page":"F73","DOI":"10.1152\/ajprenal.00362.2007","article-title":"Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures","volume":"294","author":"Natoli","year":"2008","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.14814\/phy2.12846-BIB0040|phy212846-cit-0040","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm.2171","article-title":"Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models","volume":"16","author":"Natoli","year":"2010","journal-title":"Nat. Med."},{"key":"10.14814\/phy2.12846-BIB0041|phy212846-cit-0041","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.bbadis.2011.06.012","article-title":"Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD)","volume":"1812","author":"Norman","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.14814\/phy2.12846-BIB0042|phy212846-cit-0042","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1681\/ASN.2004090800","article-title":"Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease","volume":"17","author":"Omori","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0043|phy212846-cit-0043","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00418-009-0588-y","article-title":"Doxycycline accelerates renal cyst growth and fibrosis in the pcy\/pcy mouse model of type 3 nephronophthisis, a form of recessive polycystic kidney disease","volume":"132","author":"Osten","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"10.14814\/phy2.12846-BIB0044|phy212846-cit-0044","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2369-8-12","article-title":"p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels","volume":"8","author":"Park","year":"2007","journal-title":"BMC Nephrol."},{"key":"10.14814\/phy2.12846-BIB0045|phy212846-cit-0045","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","article-title":"Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia","volume":"17","author":"Patel","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.14814\/phy2.12846-BIB0046|phy212846-cit-0046","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"Perico","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0047|phy212846-cit-0047","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1097\/01.ASN.0000144204.01352.86","article-title":"A functional floxed allele of Pkd1 that can be conditionally inactivated in\u00a0vivo","volume":"15","author":"Piontek","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0048|phy212846-cit-0048","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat. Med."},{"key":"10.14814\/phy2.12846-BIB0049|phy212846-cit-0049","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.ackd.2010.01.003","article-title":"Extrarenal manifestations of autosomal dominant polycystic kidney disease","volume":"17","author":"Pirson","year":"2010","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.14814\/phy2.12846-BIB0050|phy212846-cit-0050","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/301618","article-title":"\u201cMistakes happen\u201d: somatic mutation and disease","volume":"61","author":"Qian","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.14814\/phy2.12846-BIB0051|phy212846-cit-0051","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0092-8674(00)81793-6","article-title":"The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I","volume":"87","author":"Qian","year":"1996","journal-title":"Cell"},{"key":"10.14814\/phy2.12846-BIB0052|phy212846-cit-0052","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00280-014-2605-7","article-title":"Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in\u00a0vivo activity studies","volume":"74","author":"Reid","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.14814\/phy2.12846-BIB0053|phy212846-cit-0053","first-page":"36","article-title":"Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient","volume":"19","author":"Robinson","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.14814\/phy2.12846-BIB0054|phy212846-cit-0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/geno.1996.0584","article-title":"A gene similar to PKD1 maps to chromosome 4q22: a candidate gene for PKD2","volume":"38","author":"Schneider","year":"1996","journal-title":"Genomics"},{"key":"10.14814\/phy2.12846-BIB0055|phy212846-cit-0055","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1093\/nar\/gng012","article-title":"Rapid generation of inducible mouse mutants","volume":"31","author":"Seibler","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.14814\/phy2.12846-BIB0056|phy212846-cit-0056","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N. Engl. J.\u00a0Med."},{"key":"10.14814\/phy2.12846-BIB0057|phy212846-cit-0057","first-page":"F829","article-title":"The emerging role of transforming growth factor-beta in kidney diseases","volume":"266","author":"Sharma","year":"1994","journal-title":"Am. J.\u00a0Physiol."},{"key":"10.14814\/phy2.12846-BIB0058|phy212846-cit-0058","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.14814\/phy2.12846-BIB0059|phy212846-cit-0059","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"10.14814\/phy2.12846-BIB0060|phy212846-cit-0060","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0061|phy212846-cit-0061","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1681\/ASN.2006020136","article-title":"Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease","volume":"17","author":"Smith","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0062|phy212846-cit-0062","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.111","article-title":"A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5\u2032 end of Pkd1","volume":"73","author":"Starremans","year":"2008","journal-title":"Kidney Int."},{"key":"10.14814\/phy2.12846-BIB0063|phy212846-cit-0063","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1681\/ASN.2007101139","article-title":"Pkd1 inactivation induced in adulthood produces focal cystic disease","volume":"19","author":"Takakura","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0064|phy212846-cit-0064","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bbadis.2010.11.014","article-title":"Polycystic kidney disease: pathogenesis and potential therapies","volume":"1812","author":"Takiar","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.14814\/phy2.12846-BIB0065|phy212846-cit-0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.14814\/phy2.12846-BIB0066|phy212846-cit-0066","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1073\/pnas.0408518102","article-title":"Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease","volume":"102","author":"Tao","year":"2005","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"10.14814\/phy2.12846-BIB0067|phy212846-cit-0067","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"637","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.14814\/phy2.12846-BIB0068|phy212846-cit-0068","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nm.2068","article-title":"A mitotic transcriptional switch in polycystic kidney disease","volume":"16","author":"Verdeguer","year":"2010","journal-title":"Nat. Med."},{"key":"10.14814\/phy2.12846-BIB0069|phy212846-cit-0069","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.14814\/phy2.12846-BIB0070|phy212846-cit-0070","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.14814\/phy2.12846-BIB0071|phy212846-cit-0071","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","article-title":"Somatic inactivation of Pkd2 results in polycystic kidney disease","volume":"93","author":"Wu","year":"1998","journal-title":"Cell"},{"key":"10.14814\/phy2.12846-BIB0072|phy212846-cit-0072","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/11.16.1845","article-title":"Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease","volume":"11","author":"Wu","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.14814\/phy2.12846-BIB0073|phy212846-cit-0073","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000104818","article-title":"Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease","volume":"30","author":"Wu","year":"2007","journal-title":"Kidney Blood Press. Res."},{"key":"10.14814\/phy2.12846-BIB0074|phy212846-cit-0074","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2011.87","article-title":"WNT\/beta-catenin signaling in polycystic kidney disease","volume":"80","author":"Wuebken","year":"2011","journal-title":"Kidney Int."},{"key":"10.14814\/phy2.12846-BIB0075|phy212846-cit-0075","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.14814\/phy2.12846-BIB0076|phy212846-cit-0076","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int."},{"key":"10.14814\/phy2.12846-BIB0077|phy212846-cit-0077","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/ki.1994.122","article-title":"Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis","volume":"45","author":"Yamamoto","year":"1994","journal-title":"Kidney Int."},{"key":"10.14814\/phy2.12846-BIB0078|phy212846-cit-0078","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ndt\/gfp129","article-title":"Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)","volume":"24","author":"Zafar","year":"2009","journal-title":"Nephrol. Dial. Transplant."}],"container-title":["Physiological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.14814%2Fphy2.12846","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.14814\/phy2.12846\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T12:22:28Z","timestamp":1656764548000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.14814\/phy2.12846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.14814\/phy2.12846","archive":["Portico"],"relation":{},"ISSN":["2051-817X"],"issn-type":[{"value":"2051-817X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}